1 / 13

Synchronised Calls Concept and Funding The Inserm’s position

Synchronised Calls Concept and Funding The Inserm’s position. Richard Salives European Affairs Director , Inserm. Synchronised calls meeting / European Commission Brussels - January 15, 2014. Inserm.

herne
Télécharger la présentation

Synchronised Calls Concept and Funding The Inserm’s position

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Synchronised Calls Concept and Funding The Inserm’s position Richard Salives EuropeanAffairsDirector, Inserm Synchronised calls meeting / European Commission Brussels - January 15, 2014

  2. Inserm • Created in 1963, related to both Ministry of Research and Ministry of Health • The only French public organisation entirelydedicated to biological, medicaland public healthresearch • The largestEuropean RPO devoted to biomedicalresearch • Excellence and multidisciplinaryresearchprogrammes on • mosthumandiseases, even the rarestones • Thelinkbetween the researchlaboratory and the hospitalbed Life and health sciences progress for better and affordablehealth care for patients

  3. Inserm in figures (year 2012) • Budget:953.6 M€(incl. salaries) • Humanresources: 13,357 FTE • 5,039 permanent staff (2 153 researchers) • 2,689 contractual positions • 4,030 university-hospital personnel • 854 foreignresearchers • Research teams: 986 • Inserm publications:9,727 • 47,4% international co-publications • Patents:1,083 families • 57 licence contracts • 289 R&D contracts • FP7 (2007-2013): • 36 coordinations • 108 ERC laureates 3

  4. Inserm in Europe Inserm in the FP7 • Participates mainly in Health priority, ERC, IMI & BMS ESFRI • 4.4% coordinated by Inserm • 40% of FP7 Health research projects coordinated by French teams • 4.4% coordinated by Inserm (1st position) • Participation in 21,5% of the FP7 Health research projects (1st position) • One of the first positions in ERC : 56 StG(from 2007), 12 CoG(2013) and 40 AdG(from 2008) • 7 BMS ESFRI projects: • ECRIN, ERINHA (coordinator) • BBMRI, EUROBIOIMAGING, INFRAFRONTIER, ELIXIR, INSTRUCT Joint Programming Initiative (JPI) • Alzheimer’s disease • Antimicrobial resistance Next FP : Horizon 2020 • Societal challenges, ERC, Marie Curie Actions, Infrastructures, Future and emerging technologies, EIT (KIC Healthy Ageing) Science Europe (former representative of RPOs)

  5. The French National Alliance for Life Sciences and Health April 9, 2009 Associatemembers www.aviesan.fr/en Aviesan’smembers

  6. 10 “without walls” thematic institutes Molecular and structural bases of living organisms Cellbiology, development and evolution Cancer INCa Circulation, metabolism, and nutrition Genetics, genomics and bioinformatics Neurosciences, cognitive sciences, neurologyand psychiatry Immunology, hematology, and pneumology Microbiology and infectiousdiseases ANRS Public Health (and environmentalmedical sciences) IReSP Health Technologies Alzheimer

  7. Aviesan objectives http://www.aviesan.fr/en 7

  8. Decision-making institution? • INSERM’S POSITION One French RPO • FRANCE MS POSITION • SE MOs POSITION • ANR POSITION • FRENCH RPO’S POSITION

  9. Synchronised Calls: benefits and obstacles • Call published on Dec. 11, 2013 – Horizon 2020 / Challenge N°6 • H2020-INSO-2014 • Deadline: April 29, 2014 • CSA 2 years / Up to 5 Synchronised call initiatives funded • (EC funding: evaluationprocessco-funding, implementation and • coordination costs…) • At least 3 legalentitiesestablished in 3 different MS or AC

  10. Synchronised Calls: benefits • Improvement of the evaluationsystems (joint peerreviewevaluation • / transparency /similartreatment for proposals) • Improvement of the effectiveness of the national researchsystems • Improvement of the efficiency of researchfunding (no duplication) • Benefits for Inserm: • Benchmarking for scientificstrategies • Participation to the construction of the ERA

  11. Synchronised Calls: Obstacles • Short-time limit: deadline April 29, 2014 • Necessaryinvolvement of the National fundingagencies of the • « countries of excellence » like Germany, UK, France, Italy, Spain… • Woulditbe a successful initiative without the main Europeanresearch • actors? • Important to avoid national calls on the sametopic

  12. Synchronised Calls Initiative • Inserm supportive of the initiative • Inserm is a RPO  participation only if involvement • of the National fundingagency

  13. Thankyou for your attention

More Related